Clinical Trial Update: High-Dose Vitamin D Induction in Optic Neuritis [Phase 2]

View source ↗

Summary

Phase 2 trial of high-dose vitamin D for optic neuritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Neuritis

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: University of Calgary | Conditions: Optic Neuritis | Phase 2 | Status: TERMINATED